BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 1999
View Archived Issues
Company Profile: Axonyx
Read More
Nutropin Depot looks promising in phase III GHD trial
Read More
Uncarinic acids with anticancer potential
Read More
Evotec BioSystems and Pfizer enter drug discovery alliance
Read More
Cantab's vaccine for cocaine addiction shows encouraging phase I results
Read More
Alexion's C5 inhibitor safe and effective in phase I lupus trial
Read More
Enrollment of ABX-IL-8 phase I/II psoriasis trial completed
Read More
Phenolic hormone inhibits smooth muscle cells in prostate tissue
Read More
Selective, efficacious chemosensitizer discovered
Read More
Celltech and Chiroscience agree to merge
Read More
Unique antiobesity therapy approved in Canada
Read More
Pfizer presents new GH secretagogue at ENDO '99
Read More
Cytogen acquires Prostagen, forms joint venture with Progenics
Read More
Labeling and use changes announced for Rezulin
Read More
GnRH antagonist A-222509: coadministration with ritonavir improves potency and PK
Read More
Tabimorelin is a potent and specific GH secretagogue in healthy volunteers
Read More
Pfizer research team selects antiobesity candidate for clinical testing
Read More
Elastase inhibitor UT-77 in active development at United Therapeutics
Read More
NIAID sponsors phase III trial of varicella vaccine for prevention of shingles
Read More
Schering-Plough launches alkylating agent in second major market
Read More
Potassium channel-modulating immunosuppressants designed at Merck
Read More
Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria
Read More
Humanized monoclonal antibody for diabetic complications developed at Exocell
Read More
Sankyo presents new agents with potent blood glucose-lowering activity
Read More
New class of tachykinin antagonists synthesized at MS&D, particularly useful for emesis
Read More
International patent covers new Schering-Plough antiallergic agents
Read More
Benzocycloheptenes as PGI2 agonists in early development at Fujisawa
Read More
Ono claims new series of matrix metalloproteinase inhibitors
Read More
Orally active GnRH antagonist evaluated in preclinical models by Abbott investigators
Read More
A-198401: another compound emerges from Abbott's focus on nonpeptide GnRH antagonists
Read More